Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% |
|
-.--% | -.--% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 846.42Cr | - | ||
-3.45% | 136.53Cr | D | ||
-20.03% | 117.89Cr | B+ | ||
-34.24% | 69Cr | - | - | |
-.--% | 61Cr | - | - | |
+10.00% | 48Cr | - | ||
+1.81% | 43Cr | - | - | |
-37.52% | 28Cr | - | - | |
-67.35% | 23Cr | - | ||
+2.17% | 22Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- HS2 Stock
- Ratings Henry Schein, Inc.